SLC4A1 (Band 3 Anion Exchanger) Gene
Key regulator of erythrocyte membrane structure and ion transport, implicated in hereditary spherocytosis and distal renal tubular acidosis.
Gene Information Card
| Symbol | SLC4A1 |
|---|---|
| Full Name | Solute Carrier Family 4 Member 1 (Diego Blood Group) |
| Gene Type | Protein coding |
| Chromosomal Location | 17q21.31 |
| NCBI Gene ID | 6521 ncbi.nlm.nih.gov/gene/6521 |
| Ensembl ID | ENSG00000004939 |
| UniProt ID | P02730 |
| OMIM ID | 109270 |
| HGNC ID | 11027 |
| Aliases | AE1, EPB3, DI, SW, BND3, CD233, RTA1A, WD, WD1, WR, Wr |
Description
SLC4A1 encodes the band 3 anion exchange protein (AE1), the most abundant integral membrane protein in erythrocytes. It mediates the electroneutral exchange of chloride and bicarbonate across the plasma membrane, critical for CO2 transport and pH homeostasis. In the kidney, a truncated isoform (kAE1) is expressed in alpha-intercalated cells of the collecting duct, where it facilitates acid secretion. Mutations in SLC4A1 cause hereditary spherocytosis (HS) and distal renal tubular acidosis (dRTA). The gene also carries the Diego blood group antigens.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Hereditary spherocytosis (HS) | Loss-of-function mutations disrupt erythrocyte membrane stability, leading to spherocyte formation and hemolytic anemia. | ClinVar, OMIM #182900 |
| Distal renal tubular acidosis (dRTA) | Mutations impair kAE1 targeting or function in renal alpha-intercalated cells, causing defective acid secretion and metabolic acidosis. | ClinVar, OMIM #179800 |
| Southeast Asian ovalocytosis (SAO) | A 27-bp deletion in SLC4A1 results in a rigid, ovalocytic erythrocyte phenotype; confers resistance to malaria. | OMIM #166900 |
| Band 3 deficiency | Complete or partial loss of AE1 leads to severe hemolytic anemia and spherocytosis. | ClinVar, OMIM #109270 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Whole blood | 112.3 | High |
| Kidney | 12.5 | Medium |
| Spleen | 3.2 | Low |
| Bone marrow | 2.1 | Low |
| Liver | 0.8 | Not detected |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| Erythrocytes | High | Major site of expression |
| HEK293 | Low | Transfected models |
| K562 | Medium | Erythroleukemia cell line |
| HEK293T | Low | Transfected models |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1195C>T (p.Arg399Cys) | Missense | Common in dRTA | Impaired kAE1 trafficking to basolateral membrane |
| c.166A>G (p.Lys56Glu) | Missense | Found in HS | Disrupts ankyrin binding, membrane instability |
| c.1765_1791del (p.Val589_Val597del) | Deletion | Found in SAO | 27-bp deletion; rigid ovalocytes, malaria resistance |
| c.2573C>T (p.Pro858Leu) | Missense | Rare in dRTA | Defective anion exchange activity |
Mutation functional classification
Loss of Function (LOF)
Mutations causing hereditary spherocytosis (e.g., p.Lys56Glu) and dRTA (e.g., p.Arg399Cys) reduce membrane stability or impair anion transport.
Gain of Function (GOF)
Not reported for SLC4A1.
Dominant Negative (DN)
Dominant-negative effects observed in some dRTA mutations (e.g., p.Arg399Cys) that disrupt kAE1 dimerization and trafficking.
View complete mutation data:
Gene Ontology (GO)
| • inorganic anion exchanger activity (GO:0005452) | • bicarbonate transmembrane transporter activity (GO:0015106) |
| • inorganic anion transport (GO:0015698) | • plasma membrane (GO:0005886) |
| • cortical actin cytoskeleton (GO:0030864) | • protein binding (GO:0005515) |
Pathways
• Erythrocyte membrane protein complex (Band 3-ankyrin-spectrin)
• Bicarbonate transport (SLC4 family)
• CO2 transport in erythrocytes
Protein Summary
The SLC4A1 protein (AE1, band 3) is a 911-amino acid glycoprotein with two major domains: an N-terminal cytoplasmic domain (residues 1-403) that binds ankyrin, protein 4.1, and glycolytic enzymes, and a C-terminal membrane domain (residues 404-911) that forms the anion channel. The protein exists as a dimer in the erythrocyte membrane. In the kidney, a truncated isoform (kAE1, lacking exons 1-3) is expressed. Post-translational modifications include N-glycosylation at Asn642 and palmitoylation. The protein is essential for erythrocyte deformability and renal acid-base balance.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SLC4A1 Knockout HEK293 Cell Line | EDJ-KQ5762 | Human | 6521 | Details Get a Quote |
| SLC4A11 Knockout HEK293 Cell Line | EDJ-KQ9948 | Human | 83959 | Details Get a Quote |
| SLC4A10 Knockout HEK293 Cell Line | EDJ-KQ15279 | Human | 57282 | Details Get a Quote |
| SLC4A11 Knockout A-549 Cell Line | EDJ-KQ36853 | Human | 83959 | Details Get a Quote |
| SLC4A11 Knockout HCT 116 Cell Line | EDC08649 | Human | 83959 | Details Get a Quote |
| SLC4A11 Knockout HeLa Cell Line | EDJ-KQ36855 | Human | 83959 | Details Get a Quote |
| SLC4A1AP Knockout HEK293 Cell Line | EDJ-KQ51072 | Human | 22950 | Details Get a Quote |
| SLC4A1 Knockout HeLa Cell Line | EDJ-KQ54485 | Human | 6521 | Details Get a Quote |
| SLC4A1AP Knockout HeLa Cell Line | EDJ-KQ55661 | Human | 22950 | Details Get a Quote |
| SLC4A10 Knockout HeLa Cell Line | EDJ-KQ56828 | Human | 57282 | Details Get a Quote |
| SLC4A1 Knockout A-549 Cell Line | EDJ-KQ62971 | Human | 6521 | Details Get a Quote |
| SLC4A1AP Knockout A-549 Cell Line | EDJ-KQ64160 | Human | 22950 | Details Get a Quote |
| SLC4A10 Knockout A-549 Cell Line | EDJ-KQ65337 | Human | 57282 | Details Get a Quote |
| SLC4A1 Knockout HCT 116 Cell Line | EDJ-KQ71442 | Human | 6521 | Details Get a Quote |
| SLC4A1AP Knockout HCT 116 Cell Line | EDJ-KQ72606 | Human | 22950 | Details Get a Quote |
Displaying Records 1 To 15 Of 16 Records